Team:Poznan-BioInf/Safety

From 2013.igem.org

(Difference between revisions)
 
(One intermediate revision not shown)
Line 28: Line 28:
  <li><a href="/Team:Poznan-BioInf/Parts">Parts submitted</a></li>
  <li><a href="/Team:Poznan-BioInf/Parts">Parts submitted</a></li>
  <li class="active"><a href="/Team:Poznan-BioInf/Safety">Safety</a></li>
  <li class="active"><a href="/Team:Poznan-BioInf/Safety">Safety</a></li>
-
  <li><a href="/Team:Poznan-BioInf/Safety">Human practise</a></li>
+
  <li><a href="/Team:Poznan-BioInf/Human">Human practice</a></li>
                     </ul>
                     </ul>

Latest revision as of 02:14, 5 October 2013

Poznan-BioInf
Poznan-BioInf
iGEM

Home

We have used a safe strain of E. coli (K-12) - DH5alfa. We have been using DNA sequences originating from Bxb1, T901 and PhiC31 phages and reporting fluorescent proteins from Aequorea victoria and Discosoma sp., none of which pose any danger to humans.

We have also designed the strobe signal not only stopping expression of the final products of the system, but cutting the reading frame and the memory unit (RAD) out.

Safety forms were approved on September 22, 2013 by Evan Appleton.

Retrieved from "http://2013.igem.org/Team:Poznan-BioInf/Safety"